Literature DB >> 22901312

MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome.

S Banka1, E Howard, S Bunstone, K E Chandler, B Kerr, K Lachlan, S McKee, S G Mehta, A L T Tavares, J Tolmie, D Donnai.   

Abstract

Kabuki syndrome (KS) is a rare multi-system disorder that can result in a variety of congenital malformations, typical dysmorphism and variable learning disability. It is caused by MLL2 point mutations in the majority of the cases and, rarely by deletions involving KDM6A. Nearly one third of cases remain unsolved. Here, we expand the known genetic basis of KS by presenting five typical patients with the condition, all of whom have novel MLL2 mutation types- two patients with mosaic small deletions, one with a mosaic whole-gene deletion, one with a multi-exon deletion and one with an intragenic multi-exon duplication. We recommend MLL2 dosage studies for all patients with typical KS, where traditional Sanger sequencing fails to identify mutations. The prevalence of such MLL2 mutations in KS may be comparable with deletions involving KDM6A. These findings may be helpful in understanding the mutational mechanism of MLL2 and the disease mechanism of KS.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901312     DOI: 10.1111/j.1399-0004.2012.01955.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  19 in total

1.  A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.

Authors:  Stephen A Shinsky; Michael Hu; Valarie E Vought; Sarah B Ng; Michael J Bamshad; Jay Shendure; Michael S Cosgrove
Journal:  J Mol Biol       Date:  2014-03-27       Impact factor: 5.469

2.  Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.

Authors:  Stephen A Shinsky; Kelsey E Monteith; Susan Viggiano; Michael S Cosgrove
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 3.  Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.

Authors:  Christina N Vallianatos; Shigeki Iwase
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

Review 4.  Regulation of histone H3K4 methylation in brain development and disease.

Authors:  Erica Shen; Hennady Shulha; Zhiping Weng; Schahram Akbarian
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

5.  A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Authors:  Víctor Faundes; Geraldine Malone; William G Newman; Siddharth Banka
Journal:  J Hum Genet       Date:  2018-11-20       Impact factor: 3.172

Review 6.  Epigenetic control of the immune system: a lesson from Kabuki syndrome.

Authors:  Stefano Stagi; Anna Virginia Gulino; Elisabetta Lapi; Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

7.  Robust identification of mosaic variants in congenital heart disease.

Authors:  Kathryn B Manheimer; Felix Richter; Lisa J Edelmann; Sunita L D'Souza; Lisong Shi; Yufeng Shen; Jason Homsy; Marko T Boskovski; Angela C Tai; Joshua Gorham; Christopher Yasso; Elizabeth Goldmuntz; Martina Brueckner; Richard P Lifton; Wendy K Chung; Christine E Seidman; J G Seidman; Bruce D Gelb
Journal:  Hum Genet       Date:  2018-02-07       Impact factor: 4.132

8.  Near complete deletion of KMT2D in a college student.

Authors:  Catherine Gooch; Jaclyn Paige Souder; Matthew L Tedder; Jennifer Kerkhof; Jennifer A Lee; Raymond J Louie; Bekim Sadikovic; Robin S Fletcher; Nathaniel H Robin
Journal:  Am J Med Genet A       Date:  2022-01-18       Impact factor: 2.802

9.  Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency.

Authors:  Christopher E Gibson; Kara E Boodhansingh; Changhong Li; Laura Conlin; Pan Chen; Susan A Becker; Tricia Bhatti; Vaneeta Bamba; N Scott Adzick; Diva D De Leon; Arupa Ganguly; Charles A Stanley
Journal:  Horm Res Paediatr       Date:  2018-06-14       Impact factor: 2.852

Review 10.  Prioritization of neurodevelopmental disease genes by discovery of new mutations.

Authors:  Alexander Hoischen; Niklas Krumm; Evan E Eichler
Journal:  Nat Neurosci       Date:  2014-05-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.